---
title: Bioconjugation Services CDMOs in Asia-Pacific
path: /services/bioconjugation/apac
companies_count: 8
---

# Bioconjugation Services CDMOs in Asia-Pacific

8 published CDMOs match Bioconjugation Services in Asia-Pacific.

Facilities in this set are in Shanghai, Hangzhou, Singapore, Beijing, Bengaluru, and China.

Capabilities that show up most often in this set: Antibody-Drug Conjugate (ADC), Biologics (Monoclonal Antibodies), Biologics (Other), Peptide, and Small Molecule.

## Matching companies

- [Altruist Biologics](/companies/altruist-biologics)
  - Global CDMO offering end-to-end development and GMP manufacturing for monoclonal antibodies, bispecific antibodies, fusion proteins, recombinant proteins, and antibody-drug conjugates, with facilities in Suzhou and Hangzhou featuring up to 20,000-liter bioreactors.
- [Carbogen Amcis](/companies/carbogen-amcis)
  - Full-service CDMO offering integrated drug substance and sterile drug product development and manufacturing from early phase through commercialization, with specialized capabilities in API synthesis, process development, analytical services, and stability testing across multiple scales.
- [LOTTE Biologics](/companies/lotte-biologics)
  - LOTTE Biologics offers biologics CDMO services spanning process and analytical development, antibody manufacturing from clinical to commercial GMP, and bioconjugate manufacturing. Its operations are based at campuses in Syracuse, New York and Songdo, Incheon.
- [Pharmaron](/companies/pharmaron)
  - Premier life science CRO and CDMO offering integrated R&D and manufacturing across drug discovery, preclinical, clinical development, and commercialization for small molecules, biologics, and cell & gene therapies. 25,000+ employees across China, US, and UK.
- [Piramal Pharma Solutions](/companies/piramalpharmasolutions)
  - CDMO specializing in HPAPIs, ADCs, peptides, vaccines, and biologics with 4,700+ team members across 15 global sites and 500+ customers. Offers integrated development and manufacturing with backward integration capabilities and global program management.
- [Porton](/companies/portonpharma)
  - Porton is a global CDMO offering integrated manufacturing and development services across small molecules, peptides, oligonucleotides, biologics, and conjugates with specialized capabilities in flow chemistry, biocatalysis, and advanced therapies.
- [Syngene International](/companies/syngeneintl)
  - Innovation-led CRDMO offering integrated scientific services from early discovery through commercial manufacturing, with cGMP-compliant facilities, 5,200+ scientists, and a new 50,000-liter single-use bioreactor capacity in the U.S.
- [WuXi XDC](/companies/wuxi-xdc)
  - WuXi XDC is a leading CRDMO offering integrated discovery, development, and cGMP manufacturing services for antibody drug conjugates (ADCs) and bioconjugates, with proximately located facilities that reduce development timelines and costs.
